Trial Details
Not RecruitingBasic Information
| Clinical ID | c2073 |
|---|---|
| Identifier | EUCTR2019-002942-19-IS |
| Trial Title | NORDTREAT_The Nordic IBD treatment strategy trial a randomized controlled trial of access to a protein profile_ |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's disease and Ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Remicade Infliximab Pharmaceutical Form: Powder for concentrate for solution for infusion Trade Name: Humira Adalimumab Pharmaceutical Form: Solution for injection in pre-filled pen Trade Name: Imurel Azatioprin Pharmaceutical Form: Film-coated tablet Trade Name: Puri-nethol Merkaptopurin Pharmaceutical Form: Tablet Trade Name: Metotrexat Pharmaceutical Form: Solution for injection in pre-filled syringe Trade Name: Folacin Folic acid Pharmaceutical Form: |
Participant Information
| Sponsor | Region ebro l |
|---|---|
| City | - |
| Country/Region | Denmark;Iceland |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |